Hi, help us enhance your experience
Hi, help us enhance your experience
Hi, help us enhance your experience
636 Views
eMediNexus 05 December 2021
A consortium of 28 laboratories which monitors genomic variations in the coronavirus made a recommendation to the Center to consider giving COVID-19 vaccine booster shots topeople aged 40 years and above, amid Omicron concerns.
The Indian SARS-CoV-2 Genomics Consortium (INSACOG) said that vaccination of all remaining unvaccinated at-risk individuals should be done and a booster dose for individuals aged 40 years and over, targeting the most high-risk and high-exposure ones initially, may be considered. It stated that low levels of neutralizing antibodies from the current vaccines may not be sufficient to neutralize Omicron variant, though risk of severe disease will likely be decreased.
The consortium stated that genomic surveillance will be crucial to detect the presence of this variant early in order to put the necessary public health measures into practice… (NDTV, December 3, 2021)
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}..
Radiological Clues to Pulmonary TB with Pleural Effusion on Chest CT..
Higher Muscle Mass Lowers Risk of Incident Type 2 Diabetes..
CONFIDENCE in Combination Therapy for CKD and Type 2 Diabetes..
Unmasking Barriers to Adult Immunization..
Unmasking Future Stroke Risk in Young Women through Obstetric History..
{{Article_Title}}..
Weight-Loss Drugs may Raise Risk of Certain Eye Disorders, Study Warns..
CDSCO, ICMR Release Draft Protocols for IVD Quality Evaluation..
Delhi Battles Five-Year High in Malaria amid Monsoon Woes..
Negligence Row at Kanpur Dehat Medical College after Patient Dies, Body Left for 11 Hours..
Breakthrough in Understanding Strep a Immunity Could Speed Vaccine Development..